215 related articles for article (PubMed ID: 15121253)
21. Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
Wang YL; Li G; Wu D; Liu YW; Yao Z
Transplant Proc; 2007; 39(1):166-8. PubMed ID: 17275497
[TBL] [Abstract][Full Text] [Related]
22. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis.
Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF
Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394
[TBL] [Abstract][Full Text] [Related]
23. [The influence of tumor cells spreading in blood to relapse and distant metastasis of hepatocellular carcinoma after surgery].
LIU Y; ZHANG GT; WU MC
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1583-5. PubMed ID: 19094658
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
Cillo U; Navaglia F; Vitale A; Molari A; Basso D; Bassanello M; Brolese A; Zanus G; Montin U; D'Amico F; Ciarleglio FA; Carraro A; Bridda A; Burra P; Carraro P; Plebani M; D'Amico DF
Clin Chim Acta; 2004 Sep; 347(1-2):129-38. PubMed ID: 15313150
[TBL] [Abstract][Full Text] [Related]
25. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma.
Kar S; Carr BI
Hepatology; 1995 Feb; 21(2):403-7. PubMed ID: 7843713
[TBL] [Abstract][Full Text] [Related]
26. [Clinical implications of spontaneous and iatrogenic dissemination of tumor cells in patients with primary liver cancer].
Paterlini P
C R Seances Soc Biol Fil; 1998; 192(2):283-8. PubMed ID: 9759371
[TBL] [Abstract][Full Text] [Related]
27. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354
[TBL] [Abstract][Full Text] [Related]
28. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
29. Expression of AFPmRNA in blood of patients with recurrent hepatocellular carcinoma.
Liu Y; Zhang BH; Qian GX; Chen H; Wu MC
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):274-7. PubMed ID: 14599983
[TBL] [Abstract][Full Text] [Related]
30. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
[TBL] [Abstract][Full Text] [Related]
31. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
Marubashi S; Dono K; Nagano H; Sugita Y; Asaoka T; Hama N; Miyamoto A; Takeda Y; Umeshita K; Monden M
Transpl Int; 2007 Jul; 20(7):576-82. PubMed ID: 17425725
[TBL] [Abstract][Full Text] [Related]
32. Changes and significance of circulating hepatocellular carcinoma cells in recurrent hepatocellular carcinoma patients after combined treatment.
Liu Y; Wu M; Qian G; Zhang B; Chen H; Fu J; Huang C
Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):40-1. PubMed ID: 11242135
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview.
Wu F; Wang ZB; Chen WZ; Wang W; Gui Y; Zhang M; Zheng G; Zhou Y; Xu G; Li M; Zhang C; Ye H; Feng R
Ultrason Sonochem; 2004 May; 11(3-4):149-54. PubMed ID: 15081972
[TBL] [Abstract][Full Text] [Related]
34. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
35. Circulating tumorous cells in patients with hepatocellular carcinoma. Clinical impact and future directions.
Paterlini-Bréchot P; Vona G; Bréchot C
Semin Cancer Biol; 2000 Jun; 10(3):241-9. PubMed ID: 10936072
[TBL] [Abstract][Full Text] [Related]
36. Circulating human hepatic lipase mRNA in patients with hepatocellular carcinoma and healthy controls.
Leonhardt U; Ritzel U; Ottleben M; Ramadori G
Eur J Surg; 1999 Jun; 165(6):539-42. PubMed ID: 10433136
[TBL] [Abstract][Full Text] [Related]
37. Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cells.
Müller C; Petermann D; Pfeffel F; Oesterreicher C; Függer R
Hepatology; 1997 Apr; 25(4):896-9. PubMed ID: 9096594
[TBL] [Abstract][Full Text] [Related]
38. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma.
Wu LQ; Lu Y; Wang XF; Lv ZH; Zhang B; Yang JY
Life Sci; 2006 Jul; 79(8):744-8. PubMed ID: 16546222
[TBL] [Abstract][Full Text] [Related]
39. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
40. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
